Tatyana Feldman, M.D., specializes in the treatment of all types of lymphoma, including Hodgkin’s disease and non-Hodgkin lymphoma. She joined John Theurer Cancer Center in 2006, bringing more than 15 years of experience in internal medicine, hematology, and oncology. Prior to her current position, Dr. Feldman was on faculty in the Hematology Division at New York University Medical Center.
Dr. Feldman is actively involved in research related to lymphoma. Her research interests are focused on developing novel therapeutics and immunotherapy in Hodgkin lymphoma, T-cell lymphoma, EBV-driven lymphoma, and diffuse large B-cell lymphoma. Clinical trials which Dr. Feldman conducted have been presented at medical meetings, including some of the most well-known in the world, such as that of the American Society of Hematology.
Throughout her career, Dr. Feldman has been actively involved in fostering the educational development of physicians and nurses. She has taught courses to medical students, conducted lectures at New York University Downtown Hospital (now NewYork-Presbyterian Lower Manhattan Hospital), and Hackensack University Medical Center, and she has trained residents and fellows at New York University School of Medicine and University of Medicine and Dentistry of New Jersey.